Investments
17Portfolio Exits
4Expert Collections containing Xmark Opportunity Partners
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Xmark Opportunity Partners in 1 Expert Collection, including Pharma Startups.
Pharma Startups
5,090 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Xmark Opportunity Partners Investments
17 Investments
Xmark Opportunity Partners has made 17 investments. Their latest investment was in Aeolus Pharmaceuticals as part of their Debt on August 8, 2010.
Xmark Opportunity Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/19/2010 | Debt | Aeolus Pharmaceuticals | $1M | Yes | ||
4/4/2008 | PIPE - II | Cellectar Biosciences | $5.68M | No | ||
12/21/2007 | PIPE | Advanced Life Sciences Holdings | $19.36M | No | ||
8/13/2007 | Unattributed VC | |||||
5/9/2007 | PIPE |
Date | 8/19/2010 | 4/4/2008 | 12/21/2007 | 8/13/2007 | 5/9/2007 |
|---|---|---|---|---|---|
Round | Debt | PIPE - II | PIPE | Unattributed VC | PIPE |
Company | Aeolus Pharmaceuticals | Cellectar Biosciences | Advanced Life Sciences Holdings | ||
Amount | $1M | $5.68M | $19.36M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources |
Xmark Opportunity Partners Portfolio Exits
4 Portfolio Exits
Xmark Opportunity Partners has 4 portfolio exits. Their latest portfolio exit was Avanir Pharmaceuticals on December 02, 2014.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
12/2/2014 | Acq - P2P | 1 | |||
Date | 12/2/2014 | |||
|---|---|---|---|---|
Exit | Acq - P2P | |||
Companies | ||||
Valuation | ||||
Acquirer | ||||
Sources | 1 |